Welcome to our dedicated page for Advanced Human Imaging Limited. news (Ticker: AHI), a resource for investors and traders seeking the latest updates and insights on Advanced Human Imaging Limited. stock.
Advanced Health Intelligence Ltd (AHI) generates news that centers on digital health technology, biometric assessment partnerships, and capital markets developments. As a software publisher in the digital health space, the company regularly announces collaborations where its smartphone-based Biometric Health Assessment and related tools are integrated into healthcare, insurance, and wellness platforms.
Recent AHI news has highlighted insurance and reinsurance initiatives, including a letter of intent with Unisure Group, working with SCOR, to design and deploy a digital underwriting solution based on AHI’s Biometric Health Assessment. Other releases describe a binding term sheet with Vietnam-based OneClinic to embed AHI’s capabilities into interoperable electronic and personal health record systems, as well as collaborations with IntelliGen and Bin Farhood International Business Management Group L.L.C. to address chronic disease and support digital health in the Middle East and North Africa.
Investors following AHI news can also see updates on consumer and wellness applications, such as the use of AHI’s biometric scanning in Bearn’s rewards-based health platform and its integration into a collaboration with OnCore Innovations in the golf sector. Additional coverage includes AHI’s selection as a finalist in Singapore’s Healthcare InnoMatch program, which focuses on near-market innovations for population health and preventive care.
The news feed for the AHI stock symbol may also feature funding announcements and listing-related disclosures, such as the company’s convertible loan facility and SEC filings concerning its American Depositary Shares on Nasdaq. For readers tracking AHI, this page offers a consolidated view of company updates across partnerships, technology deployments, and regulatory communications.
Advanced Human Imaging Limited (ASX: AHI), on February 15, 2022, appointed Nick Prosser as interim Non-executive Chairman and Dr. Katherine Iscoe as Director and CEO. This follows Vlado Bosanac's transition to Head of Strategy and Revenue Growth. Prosser brings experience from his prior role at Canberra Data Centres, valued at $1.16 billion. Dr. Iscoe, a co-founder, emphasizes opportunities in remote patient monitoring and digital health solutions. An executive services agreement for Dr. Iscoe is in progress, with terms to be announced shortly.
Advanced Human Imaging Limited (ASX: AHI, NASDAQ: AHI) has signed a binding term sheet with Vertica Health PTY Ltd, a remote monitoring provider based in South Africa. This partnership will integrate AHI's MultiScan Software Development Kit into Vertica's health risk management application, enhancing user capabilities in monitoring health risks such as metabolic syndrome and cardiovascular disease. CEO Vlado Bosanac highlighted the potential positive impact on patient outcomes and preventive healthcare delivery in South Africa and beyond.
Advanced Human Imaging Limited (ASX: AHI) announced a binding term sheet with Activate Health OÜ, a digital health provider from Estonia, on January 26, 2022. This partnership will enhance Activate's digital therapeutic platform for metabolic syndrome, affecting nearly one-third of adults globally. AHI's MultiScan Software Development Kit will integrate with Activate's platform, enabling users to assess chronic disease risk and improve health outcomes. The collaboration aims to promote prevention-focused healthcare solutions and improve the efficiency of health audits.
Advanced Human Imaging Limited (ASX:AHI, NASDAQ:AHI) has signed a binding term sheet with Peruvian telemedicine company Nextmedicall. This partnership aims to integrate AHI's MultiScan Software Development Kit into Nextmedicall's platform, enabling remote health assessments via BodyScan and FaceScan technologies. Nextmedicall plans to use this integration for early detection of chronic diseases across Latin America. The implementation is set to begin within 120 days and follows a successful pilot program with Entel Chile.
Advanced Human Imaging Limited (ASX:AHI, NASDAQ:AHI) has successfully closed its U.S. initial public offering, raising US$10.5 million by issuing 1,000,000 units priced at US$10.50 each. Each unit includes two ADSs and one warrant, with an exercise price of US$5.52 per ADS. The ADSs began trading on Nasdaq on November 19, 2021.
The funds will primarily support research, product development, and marketing, with additional investments in synergistic companies.
Advanced Human Imaging Limited (ASX:AHI) (NASDAQ:AHI) announced the pricing of its U.S. initial public offering, offering 1,000,000 units at US$10.50 each. Each unit includes two American Depositary Shares (ADSs) and a warrant for one ADS, with gross proceeds expected to reach US$10.5 million. The ADSs will begin trading on Nasdaq under the symbol "AHI" from November 19, 2021. Proceeds will fund research, product development, and general corporate purposes. The company has also granted underwriters a 45-day option for an additional 300,000 ADSs.